Current Clinical Trials

All trials are individually linked to site for more extensive information on the study.

Breast Cancer

A011202:  Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (CT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

NSABP B-51: a Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

CCTG MA.39 TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer

Colorectal Cancer

NRG-GI008: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Lung Cancer

ALCHEMIST MAIN Trial:  A151216   Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

ALCHEMIST E4512:  A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer:  Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Prostate Cancer

NRG GU005: Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for localized intermediate risk prostate cancer. 

Supportive Care

SWOG S2013:  Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

A222004: A Randomized Phase III Trial of Olanzapine Versus Megastrol Acetate for Cancer-Associated Anorexia